November 20, 2017
PARIS–(BUSINESS WIRE)–EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI – Eligible PEA – SME), the pioneer of 2D/3D orthopedic medical imaging, today announced that Marie Meynadier, Chief Executive Officer, is scheduled to present at the 29th Annual Piper Jaffray Healthcare Conference in New York, NY.
|Event:||29th Annual Piper Jaffray Healthcare Conference|
|Date:||Wednesday, November 29, 2017|
|Time:||10:30 am ET / 4:30 pm CET|
Investors attending the conference who would like to schedule a one-on-one meeting with EOS imaging management may do so by contacting their Piper Jaffray representative, or Emma Poalillo of The Ruth Group at email@example.com.
About EOS imaging
EOS imaging designs, develops, and markets EOS®, an innovative medical imaging service dedicated to osteo-articular pathologies and orthopaedics, as well as the associated solutions. The Company is authorized to market in 51 countries, including the United States (FDA), Japan, China and the European Union (EC). It posted revenues of €30.8 million in 2016 and employed 132 people at December 2016, including an R&D team of 43 engineers. The group is based in Paris and has five subsidiaries: in Besançon (France), Cambridge (Massachusetts), Montreal (Canada), Frankfurt (Germany) and Singapore.
EOS imaging has been selected to integrate the EnterNext © PEA – SME 150 index, composed of 150 French, listed companies on the Euronext markets in Paris.
EOS imaging is listed on Compartment C of Euronext Paris
ISIN: FR0011191766 – Ticker: EOSI
Pierre Schwich, +33 (0)1 55 25 61 24
Financial communication and investor relations
Pierre Laurent, +33 (0)1 44 71 94 96
The Ruth Group (US)
Joanna Zimmerman, 646-536-7006